# The Effect of Two Aspirin Dosing Strategies for Obese Women at High Risk for Preeclampsia

> **NCT03735433** · PHASE4 · TERMINATED · sponsor: **Ohio State University** · enrollment: 152 (actual)

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** 162mg aspirin dose

## Key facts

- **NCT ID:** NCT03735433
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-01-15
- **Primary completion:** 2023-01-30
- **Final completion:** 2024-03-01
- **Target enrollment:** 152 (ACTUAL)
- **Why stopped:** futility
- **Last updated:** 2024-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03735433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03735433, "The Effect of Two Aspirin Dosing Strategies for Obese Women at High Risk for Preeclampsia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03735433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*